A Phase 3 Study to Assess the Efficacy and Safety of PK101 in Patients With Knee Osteoarthritis

Clinical trial NCT04858659 · UNKNOWN

Trial details

NCT number: NCT04858659
Sponsor: PMG Pharm Co., Ltd
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Knee Osteoarthritis

Start date: 2021-05-20
Primary completion: 2022-03-15
Enrollment: 354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.